Clearance of hepatitis C virus (HCV) via antiviral treatment changes the course of liver disease. We evaluated the benefit of sustained virologic response (SVR) in patients with HCV and cirrhosis without (stage 1) and with (stage 2) esophageal varices (EV).

Di Marco, V., Calvaruso, V., Ferraro, D., Bavetta, M., Cabibbo, G., Conte, E., et al. (2016). Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension. GASTROENTEROLOGY, 151(1), 130-139.e2-139.e2 [10.1053/j.gastro.2016.03.036].

Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension

DI MARCO, Vito;CALVARUSO, Vincenza;FERRARO, Donatella;BAVETTA, Maria Grazia;CABIBBO, Giuseppe;CONTE, Elisabetta;CAMMA', Calogero;GRIMAUDO, Stefania;PIPITONE, Rosaria Maria;SIMONE, Fabio;CRAXI, Antonio
2016

Abstract

Clearance of hepatitis C virus (HCV) via antiviral treatment changes the course of liver disease. We evaluated the benefit of sustained virologic response (SVR) in patients with HCV and cirrhosis without (stage 1) and with (stage 2) esophageal varices (EV).
Di Marco, V., Calvaruso, V., Ferraro, D., Bavetta, M., Cabibbo, G., Conte, E., et al. (2016). Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension. GASTROENTEROLOGY, 151(1), 130-139.e2-139.e2 [10.1053/j.gastro.2016.03.036].
File in questo prodotto:
File Dimensione Formato  
Gastroenterology 2016.pdf

non disponibili

Dimensione 1.05 MB
Formato Adobe PDF
1.05 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/191041
Citazioni
  • ???jsp.display-item.citation.pmc??? 39
  • Scopus 106
  • ???jsp.display-item.citation.isi??? 100
social impact